ID

15658

Description

A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02352948

Link

https://clinicaltrials.gov/show/NCT02352948

Keywords

Versions (1)
  1. 6/7/16 6/7/16 -
Uploaded on

June 7, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT02352948

English

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT02352948

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged at least 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
documented evidence of nsclc (stage iiib/ iv disease)
Description

Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007131
disease progression or recurrence after both a platinum-based chemotherapy regimen and at least 1 additional regimen for treatment of nsclc
Description

Disease Progression | Disease recurrence | Chemotherapy Regimen Platinum-Based | Chemotherapy Regimen Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0679254
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1514162
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0007131
world health organization (who) performance status of 0 or 1
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
estimated life expectancy more than 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior exposure to any anti-pd-1 or anti-pd-l1 antibody or anti ctla4
Description

Exposure to Programmed Cell Death Protein 1 Antibodies | Exposure to Antigens, CD274 Antibodies | Exposure to cytotoxic T-lymphocyte antigen 4 Antibodies

Data type

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C2986635
UMLS CUI [1,3]
C0003241
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C3203086
UMLS CUI [2,3]
C0003241
UMLS CUI [3,1]
C0332157
UMLS CUI [3,2]
C0111208
UMLS CUI [3,3]
C0003241
brain metastases or spinal cord compression unless asymptomatic, treated and stable (not requiring steroids)
Description

Metastatic malignant neoplasm to brain | Compression of spinal cord | Metastatic malignant neoplasm to brain Asymptomatic | Metastatic malignant neoplasm to brain Treated | Metastatic malignant neoplasm to brain Stable status | Compression of spinal cord Asymptomatic | Compression of spinal cord Treated | Compression of spinal cord Stable status | Steroids

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0037926
UMLS CUI [3,1]
C0220650
UMLS CUI [3,2]
C0231221
UMLS CUI [4,1]
C0220650
UMLS CUI [4,2]
C1522326
UMLS CUI [5,1]
C0220650
UMLS CUI [5,2]
C0205360
UMLS CUI [6,1]
C0037926
UMLS CUI [6,2]
C0231221
UMLS CUI [7,1]
C0037926
UMLS CUI [7,2]
C1522326
UMLS CUI [8,1]
C0037926
UMLS CUI [8,2]
C0205360
UMLS CUI [9]
C0038317
active or prior documented autoimmune disease within the past 2 years
Description

Autoimmune Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0004364
evidence of severe or uncontrolled systemic disease, including active bleeding diatheses or active infections including hepatitis b, c and hiv
Description

severe systemic disease | Systemic disease Uncontrolled | Hemorrhagic Disorders | Infection | Hepatitis B | Hepatitis C | HIV

Data type

boolean

Alias
UMLS CUI [1]
C0973444
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0019087
UMLS CUI [4]
C3714514
UMLS CUI [5]
C0019163
UMLS CUI [6]
C0019196
UMLS CUI [7]
C0019682
any unresolved toxicity ctcae (common terminology criteria of adverse events) >grade 2 from previous anti-cancer therapy
Description

Toxic effect Unresolved | CTCAE | cancer treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0443342
UMLS CUI [2]
C1516728
UMLS CUI [3]
C0920425
known egfr tk activating mutations or alk rearrangements
Description

Mutation Activating Epidermal growth factor receptor inhibitor | ALK gene Rearrangement

Data type

boolean

Alias
UMLS CUI [1,1]
C0026882
UMLS CUI [1,2]
C1879547
UMLS CUI [1,3]
C1443775
UMLS CUI [2,1]
C1332080
UMLS CUI [2,2]
C0017287
any prior grade ≥3 immune-related adverse event (irae) while receiving any previous immunotherapy agent, or any unresolved irae >grade 1
Description

Adverse event Immune system | Immunotherapy Pharmaceutical Preparations | Immune system Adverse event Unresolved

Data type

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0020962
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0013227
UMLS CUI [3,1]
C0020962
UMLS CUI [3,2]
C0877248
UMLS CUI [3,3]
C0443342
active or prior documented inflammatory bowel disease (eg, crohn's disease, ulcerative colitis)
Description

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Data type

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0010346
UMLS CUI [3]
C0009324
Back to the top of the page

Similar models

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT02352948

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma
Item
documented evidence of nsclc (stage iiib/ iv disease)
boolean
C0007131 (UMLS CUI [1])
Disease Progression | Disease recurrence | Chemotherapy Regimen Platinum-Based | Chemotherapy Regimen Non-Small Cell Lung Carcinoma
Item
disease progression or recurrence after both a platinum-based chemotherapy regimen and at least 1 additional regimen for treatment of nsclc
boolean
C0242656 (UMLS CUI [1])
C0679254 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1514162 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0007131 (UMLS CUI [4,2])
WHO performance status scale
Item
world health organization (who) performance status of 0 or 1
boolean
C1298650 (UMLS CUI [1])
Life Expectancy
Item
estimated life expectancy more than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exposure to Programmed Cell Death Protein 1 Antibodies | Exposure to Antigens, CD274 Antibodies | Exposure to cytotoxic T-lymphocyte antigen 4 Antibodies
Item
prior exposure to any anti-pd-1 or anti-pd-l1 antibody or anti ctla4
boolean
C0332157 (UMLS CUI [1,1])
C2986635 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,3])
C0332157 (UMLS CUI [2,1])
C3203086 (UMLS CUI [2,2])
C0003241 (UMLS CUI [2,3])
C0332157 (UMLS CUI [3,1])
C0111208 (UMLS CUI [3,2])
C0003241 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain | Compression of spinal cord | Metastatic malignant neoplasm to brain Asymptomatic | Metastatic malignant neoplasm to brain Treated | Metastatic malignant neoplasm to brain Stable status | Compression of spinal cord Asymptomatic | Compression of spinal cord Treated | Compression of spinal cord Stable status | Steroids
Item
brain metastases or spinal cord compression unless asymptomatic, treated and stable (not requiring steroids)
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])
C0220650 (UMLS CUI [3,1])
C0231221 (UMLS CUI [3,2])
C0220650 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C0220650 (UMLS CUI [5,1])
C0205360 (UMLS CUI [5,2])
C0037926 (UMLS CUI [6,1])
C0231221 (UMLS CUI [6,2])
C0037926 (UMLS CUI [7,1])
C1522326 (UMLS CUI [7,2])
C0037926 (UMLS CUI [8,1])
C0205360 (UMLS CUI [8,2])
C0038317 (UMLS CUI [9])
Autoimmune Diseases
Item
active or prior documented autoimmune disease within the past 2 years
boolean
C0004364 (UMLS CUI [1])
severe systemic disease | Systemic disease Uncontrolled | Hemorrhagic Disorders | Infection | Hepatitis B | Hepatitis C | HIV
Item
evidence of severe or uncontrolled systemic disease, including active bleeding diatheses or active infections including hepatitis b, c and hiv
boolean
C0973444 (UMLS CUI [1])
C0442893 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0019087 (UMLS CUI [3])
C3714514 (UMLS CUI [4])
C0019163 (UMLS CUI [5])
C0019196 (UMLS CUI [6])
C0019682 (UMLS CUI [7])
Toxic effect Unresolved | CTCAE | cancer treatment
Item
any unresolved toxicity ctcae (common terminology criteria of adverse events) >grade 2 from previous anti-cancer therapy
boolean
C0600688 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [2])
C0920425 (UMLS CUI [3])
Mutation Activating Epidermal growth factor receptor inhibitor | ALK gene Rearrangement
Item
known egfr tk activating mutations or alk rearrangements
boolean
C0026882 (UMLS CUI [1,1])
C1879547 (UMLS CUI [1,2])
C1443775 (UMLS CUI [1,3])
C1332080 (UMLS CUI [2,1])
C0017287 (UMLS CUI [2,2])
Adverse event Immune system | Immunotherapy Pharmaceutical Preparations | Immune system Adverse event Unresolved
Item
any prior grade ≥3 immune-related adverse event (irae) while receiving any previous immunotherapy agent, or any unresolved irae >grade 1
boolean
C0877248 (UMLS CUI [1,1])
C0020962 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0020962 (UMLS CUI [3,1])
C0877248 (UMLS CUI [3,2])
C0443342 (UMLS CUI [3,3])
Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis
Item
active or prior documented inflammatory bowel disease (eg, crohn's disease, ulcerative colitis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0009324 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial